Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1 Results

Intervention Indication Therapeutic Area Year Actions
Histamine dihydrochloride (Ceplene) in combination with low dose interleukin-2 as maintenance treatment for acute myeloid leukaemia Histamine dihydrochloride (Ceplene) , Low-dose aldesluekin Acute myeloid leukaemia (AML) Haematological Cancer and Lymphomas 2019 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications